Vellos is part of a University of Cambridge consortium, called Cambridge Neuroworks, that helps pioneers in neurotechnology transform brain health.
The programme accelerates the development of groundbreaking solutions for neurological and neuropsychiatric conditions, by uniting pioneering researchers, engineers, clinicians and industry leaders. It provides the funding, expertise and network needed to turn radical ideas into scalable, real-world impact. The programme is powered by the UK Government's Advanced Research and Invention Agency (ARIA).
